What’s New in General Surgery: Endocrine Surgery
- 30 November 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 201 (5) , 746-753
- https://doi.org/10.1016/j.jamcollsurg.2005.07.007
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- BRAF mutation in thyroid cancerEndocrine-Related Cancer, 2005
- Dose-Dependent Generation of RET/PTC in Human Thyroid Cells after in Vitro Exposure to γ-Radiation: A Model of Carcinogenic Chromosomal Rearrangement Induced by Ionizing RadiationJournal of Clinical Endocrinology & Metabolism, 2005
- Troglitazone, the Peroxisome Proliferator-Activated Receptor-γ Agonist, Induces Antiproliferation and Redifferentiation in Human Thyroid Cancer Cell LinesThyroid®, 2005
- Aurora B Overexpression Associates with the Thyroid Carcinoma Undifferentiated Phenotype and Is Required for Thyroid Carcinoma Cell ProliferationJournal of Clinical Endocrinology & Metabolism, 2005
- Anaplastic Carcinoma of the Thyroid—Will Aurora B Light a Path for Treatment?Journal of Clinical Endocrinology & Metabolism, 2005
- Challenging Dogma in Thyroid Cancer Molecular Genetics—Role ofRET/PTCandBRAFin Tumor InitiationJournal of Clinical Endocrinology & Metabolism, 2004
- Low Frequency of BRAFT1796A Mutations in Childhood Thyroid CarcinomasJournal of Clinical Endocrinology & Metabolism, 2004
- BRAFMutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid CarcinomasJournal of Clinical Endocrinology & Metabolism, 2004
- BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary CarcinomasJournal of Clinical Endocrinology & Metabolism, 2003
- RASPoint Mutations and PAX8-PPARγ Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular CarcinomaJournal of Clinical Endocrinology & Metabolism, 2003